申请人:NPS Pharmaceuticals, Inc.
公开号:US20040039014A1
公开(公告)日:2004-02-26
The present invention features compounds active at both the serotonin reuptake site and the N-methyl-D-aspartate (NMDA) receptor and the use of such compounds for treating different disorders. Compounds having activity at the serotonin reuptake site and the NMDA receptor (“multi-active compounds”) can be used to treat different types of disorders such as depression, obsessive-compulsive disorders (OCD), sleep, disorders, sexual dysfunction, and eating disorders. Preferably, the multi-active compounds are used to treat depression.
本发明的特点是活性化合物同时作用于5-羟色胺再摄取位点和N-甲基-D-天冬酰胺(NMDA)受体,并利用这些化合物治疗不同的疾病。在5-羟色胺再摄取位点和NMDA受体具有活性的化合物(“多活性化合物”)可用于治疗不同类型的疾病,如抑郁症、强迫症障碍(OCD)、睡眠障碍、性功能障碍和进食障碍。最好是,多活性化合物用于治疗抑郁症。